(Q38128763)

29 August 2017

title

Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? (English)

1 reference

29 August 2017

1 reference

Nicole R Wulf

1

1 reference

29 August 2017

Karl A Matuszewski

series ordinal

2

1 reference

29 August 2017

publication date

1 September 2013

1 reference

American Journal of Health-System Pharmacy

29 August 2017

published in

1 reference

29 August 2017

volume

70

1 reference

29 August 2017

issue

17

1 reference

29 August 2017

page(s)

1483-1494

1 reference

Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Sulfonamide allergy and cross-reactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Allergic adverse reactions to sulfonamides.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Difference in Risks of Allergic Reaction to Sulfonamide Drugs Based on Chemical Structure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Sulfonamide cross-reactivity: fact or fiction?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Studies of human IgE to a sulfonamide determinant

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Idiosyncratic drug reactions: the reactive metabolite syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

T-cell involvement in drug-induced acute generalized exanthematous pustulosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Use of optical biosensor technology to study immunological cross-reactivity between different sulfonamide drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Sulfamethoxazole is metabolized to the hydroxylamine in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Allergic contact blepharoconjunctivitis from dorzolamide

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Anaphylactic shock after a single oral intake of acetazolamide

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Presumed "sulfa allergy" in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Anaphylactic drug reaction to celecoxib and sulfamethoxazole: cross reactivity or coincidence?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Celecoxib-induced erythema multiforme with glyburide cross-reactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Allergic skin reaction to celecoxib

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Celecoxib allergies and cross-reactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Celecoxib-induced cholestatic hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Celecoxib-induced acute pancreatitis and hepatitis: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Selective celecoxib-associated anaphylactoid reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Sulfonamide allergy without cross-reactivity to celecoxib

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Immunologic tolerability profile of celecoxib

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Safety of celecoxib in individuals allergic to sulfonamide: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Anaphylaxis to oral furosemide

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Rapid oral desensitization to furosemide

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Ethacrynic acid and the sulfa-sensitive patient

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Anaphylaxis to intravenous furosemide

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

A successful rapid desensitization protocol in a loop diuretic allergic patient

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Furosemide challenge in patients with heart failure and adverse reactions to sulfa-containing diuretics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Hydrochlorothiazide-induced angioedema in a patient allergic to sulfonamide antibiotics: evidence from a case report and a review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Severe allergic reaction to hydrochlorothiazide mimicking septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Amprenavir-induced maculopapular exanthem followed by desensitization in a patient with late-stage human immunodeficiency virus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Predicting possible zonisamide hypersensitivity syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Concomitant sensitization to enoxolone and mafenide in a topical medicament

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

Allergic contact dermatitis from topical mafenide

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP120291

31 March 2020

Identifiers

DOI

10.2146/AJHP120291

1 reference

29 August 2017

1 reference